Alpha-synuclein in cutaneous small nerve fibers

Despite progression in the development of pharmacological therapy, treatment of alpha synucleinopathies, such as Parkinson’s disease (PD) and some atypical parkinsonism syndromes, is still challenging. To date, our knowledge of the mechanisms whereby the pathological form of alpha-synuclein causes s...

Descripción completa

Detalles Bibliográficos
Autores principales: Siepmann, Timo, Illigens, Ben Min-Woo, Barlinn, Kristian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087811/
https://www.ncbi.nlm.nih.gov/pubmed/27822045
http://dx.doi.org/10.2147/NDT.S117423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5087811/
https://www.ncbi.nlm.nih.gov/pubmed/27822045
http://dx.doi.org/10.2147/NDT.S117423

Ejemplares similares